Intravenous Solutions in Great Demand Following COVID-19 Global Pandemic

Intravenous IV solutions market

iData Research (“iData”), a global consulting and market research firm, has released updated insights in the U.S. Intravenous (IV) solutions market, addressing company-level information including manufacturer, and type of IV solution. Based on the data, the market decreased in 2020, largely throughout Q2, and is now showing signs of recovery to once again reach pre-pandemic levels. 

MedSKU (™) is an accurate brand-level custom solution from iData that provides a level of detail for a go-to strategy of medical device companies of any size. The analysis of the IV solutions market is one of many studies that provide up-to-date data and trends on the ASPs, units sold, unit share, revenue, and revenue shares of the top-performing products in the U.S. and 20 other countries worldwide.

iData’s analysis covers over 1700 facilities in the US alone and just under 400 related SKUs to develop insights on prices, units sold, and market shares for every IV solution. Based on the number of injections and solutions sold in the first quarter of 2021, drug reconstitution solutions saw a massive increase. Similarly, during the first quarter of 2021, irrigation solution units sold, are on the rise and approaching the previous year’s volume.

The top manufacturers of IV solutions are Baxter and B. Braun. Baxter dominates the market for IV solutions with its strong presence in sodium chloride injection. Data from the first quarter of 2021 shows a slight decrease in Baxter’s market share in the overall IV solutions sales revenue compared to the previous quarter. However, the company has maintained the leading revenue share position for the last few quarters.

“Following the global COVID-19 pandemic, there was a decrease in demand for IV solutions in Q2’20”, says Dr. Kamran Zamanian, Senior Partner and CEO of iData Research, “However, the market is showing signs of recovery in terms of sales volume to pre-pandemic levels as demand increases.”

MedSKU uses primary data from 1000s of reporting hospitals and ambulatory surgery centers (ASCs) to gather purchase order data and sales information. After combining this with rigorous primary research, ongoing for over a decade, MedSKU is able to deliver a cross-verified and highly accurate depiction of the market, unlike any other.

Follow the link below to view the MedSKU solution in detail:

For Further Information

More insights like this can be found in the latest reports by iData. Please email us at or register online for a brochure and synopsis.


Request a MedSKU Demo

Leave a Reply